These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
93 related articles for article (PubMed ID: 3468322)
1. Factors influencing the recovery of dopamine sulfate in the assay of phenol sulfotransferase. Toth LA; Kao G; Elchisak MA Life Sci; 1987 Feb; 40(5):473-80. PubMed ID: 3468322 [TBL] [Abstract][Full Text] [Related]
2. A modified Ecteola cellulose assay for M and P phenol sulfotransferase. Whittemore RM; Roth JA Biochem Pharmacol; 1985 May; 34(10):1647-52. PubMed ID: 3859294 [TBL] [Abstract][Full Text] [Related]
3. Dopamine sulfate formation and phenol sulfotransferase activity in dog and human platelets. Toth LA; Scott MC; Elchisak MA Life Sci; 1986 Aug; 39(6):519-26. PubMed ID: 3461232 [TBL] [Abstract][Full Text] [Related]
5. Purification and kinetic characterization of a dopamine-sulfating form of phenol sulfotransferase from human brain. Whittemore RM; Pearce LB; Roth JA Biochemistry; 1985 May; 24(10):2477-82. PubMed ID: 3860259 [TBL] [Abstract][Full Text] [Related]
6. Phenol sulfotransferase in human lung. Barańczyk-Kuźma A Biochem Med Metab Biol; 1986 Feb; 35(1):18-30. PubMed ID: 3465328 [TBL] [Abstract][Full Text] [Related]
10. A fluorometric assay for quantitating phenol sulfotransferase activities in homogenates of cells and tissues. Arand M; Robertson LW; Oesch F Anal Biochem; 1987 Jun; 163(2):546-51. PubMed ID: 3477964 [TBL] [Abstract][Full Text] [Related]
11. Human platelet phenol sulfotransferase: partial purification and detection of two forms of the enzyme. Butler PR; Anderson RJ; Venton DL J Neurochem; 1983 Sep; 41(3):630-9. PubMed ID: 6576122 [TBL] [Abstract][Full Text] [Related]
12. Pharmacological characterization of dopamine sulfoconjugation by human platelets. Toth LA; Elchisak MA J Pharmacol Exp Ther; 1987 Feb; 240(2):359-63. PubMed ID: 3492601 [TBL] [Abstract][Full Text] [Related]
13. Human liver phenol sulfotransferase: assay conditions, biochemical properties and partial purification of isozymes of the thermostable form. Campbell NR; Van Loon JA; Weinshilboum RM Biochem Pharmacol; 1987 May; 36(9):1435-46. PubMed ID: 3472524 [TBL] [Abstract][Full Text] [Related]
14. Properties and localization of the sulfate-activating system in rat brain. Brion F; Schwartz JC; Vargas F J Neurochem; 1987 Apr; 48(4):1171-7. PubMed ID: 3493327 [TBL] [Abstract][Full Text] [Related]
15. Direct measurement of dopamine O-sulfate in plasma and cerebrospinal fluid. Scott MC; Elchisak MA J Chromatogr; 1987 Jan; 413():17-23. PubMed ID: 3558665 [TBL] [Abstract][Full Text] [Related]
16. Physical characterization of a monoamine-sulfating form of phenol sulfotransferase from human platelets. Heroux JA; Roth JA Mol Pharmacol; 1988 Aug; 34(2):194-9. PubMed ID: 3166104 [TBL] [Abstract][Full Text] [Related]
17. Inhibition of M and P phenol sulfotransferase by analogues of 3'-phosphoadenosine-5'-phosphosulfate. Rens-Domiano SS; Roth JA J Neurochem; 1987 May; 48(5):1411-5. PubMed ID: 3470439 [TBL] [Abstract][Full Text] [Related]
18. Hepatic dopamine sulfotransferases in untreated rats and in rats subjected to endocrine or hypertension-related treatments. Singer SS; Palmert MR; Redman MD; Leahy DM; Feeser TC; Lucarelli MJ; Volkwein LS; Bruns M Hepatology; 1988; 8(6):1511-20. PubMed ID: 3192164 [TBL] [Abstract][Full Text] [Related]